MY8700554A - Lipophilic muramyl pertides processes for their preparation and their use - Google Patents

Lipophilic muramyl pertides processes for their preparation and their use

Info

Publication number
MY8700554A
MY8700554A MY554/87A MY8700554A MY8700554A MY 8700554 A MY8700554 A MY 8700554A MY 554/87 A MY554/87 A MY 554/87A MY 8700554 A MY8700554 A MY 8700554A MY 8700554 A MY8700554 A MY 8700554A
Authority
MY
Malaysia
Prior art keywords
pertides
processes
preparation
lipophilic muramyl
muramyl
Prior art date
Application number
MY554/87A
Other languages
English (en)
Inventor
Lajos Dr Tarcsay
Gerhard Dr Baschang
Albert Dr Hartman
Jaroslav Dr Stanek
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MY8700554A publication Critical patent/MY8700554A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MY554/87A 1979-07-25 1987-12-30 Lipophilic muramyl pertides processes for their preparation and their use MY8700554A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH689379 1979-07-25
AU66581/81A AU6658181A (en) 1979-07-25 1981-01-23 Increasing antibiotic action of antibiotics

Publications (1)

Publication Number Publication Date
MY8700554A true MY8700554A (en) 1987-12-31

Family

ID=34862371

Family Applications (1)

Application Number Title Priority Date Filing Date
MY554/87A MY8700554A (en) 1979-07-25 1987-12-30 Lipophilic muramyl pertides processes for their preparation and their use

Country Status (27)

Country Link
US (2) US4414204A (xx)
EP (1) EP0025495B1 (xx)
JP (1) JPS5649397A (xx)
KR (1) KR840001617B1 (xx)
AU (2) AU541147B2 (xx)
CA (1) CA1183129A (xx)
CS (1) CS276965B6 (xx)
CY (1) CY1381A (xx)
DD (1) DD153843A5 (xx)
DE (1) DE3068304D1 (xx)
DK (1) DK161025C (xx)
ES (1) ES493633A0 (xx)
FI (1) FI75578C (xx)
GR (1) GR69314B (xx)
HK (1) HK85787A (xx)
HU (1) HU188861B (xx)
IE (1) IE50145B1 (xx)
IL (1) IL60676A (xx)
MX (1) MX9203368A (xx)
MY (1) MY8700554A (xx)
NO (1) NO157177C (xx)
NZ (1) NZ194432A (xx)
PL (2) PL131613B1 (xx)
PT (1) PT71607A (xx)
SG (1) SG38187G (xx)
SU (2) SU1277905A3 (xx)
ZA (1) ZA804487B (xx)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
DK330880A (da) * 1979-08-03 1981-02-04 Beecham Group Ltd Fremgangsmaade til fremstilling af clavulansyrederivater
FI803077A (fi) * 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider
EP0053893B1 (en) * 1980-12-09 1985-03-20 Beecham Group Plc Derivatives of clavulanic acid, their preparation and their use
US4562182A (en) * 1980-12-23 1985-12-31 Beecham Group P.L.C. Compounds containing beta-lactams
EP0056560A1 (de) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika
GR78246B (xx) * 1981-01-23 1984-09-26 Ciba Geigy Ag
FI79330C (fi) * 1982-07-23 1989-12-11 Ciba Geigy Ag Foerfarande foer framstaellning av farmakologiskt verkande muramylpeptid-n-(2-fosfatidyloxietyl)-amider.
US5189017A (en) * 1982-07-23 1993-02-23 Ciba-Geigy Corporation Use of sugar derivatives for the prophylaxis and treatment of virus infections
EP0102319B1 (de) * 1982-07-23 1987-08-19 Ciba-Geigy Ag Verwendung von Muramylpeptiden oder deren Analogen zur Prophylaxe und Therapie von Virusinfektionen
US5334583A (en) * 1982-07-23 1994-08-02 Ciba-Geigy Corp. Use of sugar derivatives for the prophylaxis and treatment of virus infections
US4746651A (en) * 1983-11-01 1988-05-24 Scripps Clinic And Research Foundation Antimicrobial chemotherapeutic potentiation using substituted nucleoside derivatives
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir
DE3572491D1 (en) * 1984-07-25 1989-09-28 Ciba Geigy Ag Phosphatidyl compounds, process for their preparation and their use
EP0174912A3 (de) * 1984-09-13 1986-06-04 Ciba-Geigy Ag Phosphorverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
CA1260393A (en) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes of synthetic lipids
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US4873322A (en) * 1986-01-24 1989-10-10 Ciba-Geigy Corporation Saccharide derivatives and processes for their manufacture
US4916118A (en) * 1986-08-18 1990-04-10 Board Of Regents, The University Of Texas System Pharmaceutical administration systems containing chemotactic peptides
US5149529A (en) * 1988-04-08 1992-09-22 Board Of Trustees Of Leland Chiron Corporation Compositions and treatment for herpes simplex
US4950645A (en) * 1988-07-08 1990-08-21 Immunotherapeutics, Inc. Composition for macrophage activation
US5416070A (en) * 1988-07-08 1995-05-16 Immunotherapeutics, Inc. Composition for macrophage activation
US4994440A (en) * 1989-02-13 1991-02-19 Creaven Patrick J Method for the treatment of renal cell carcinoma
GB9320820D0 (en) * 1993-10-08 1993-12-01 Biokine Tech Ltd Compounds for medicinal use
US6156319A (en) 1994-07-25 2000-12-05 The Trustees Of The University Of Pennsylvania Soluble herpesvirus glycoprotein complex vaccine
US6080427A (en) * 1997-04-17 2000-06-27 Bristol-Myers Squibb Company Cefadroxil monohydrate tablet formulation
AUPP059897A0 (en) * 1997-11-27 1998-01-08 Fujisawa Pharmaceutical Co., Ltd. New use of bicozamycin
US20040029842A1 (en) * 2001-12-18 2004-02-12 Gardner Wallace J. Triglyceride lowering, common cold and pneumonia prevention composition comprising tetracycline, and methods of treating or preventing diseases using same
WO2005013918A2 (en) 2003-02-28 2005-02-17 The Trustees Of The University Of Pennsylvania Compositions, methods and kits relating to poxvirus subunit vaccines
US20050079187A1 (en) * 2003-10-14 2005-04-14 Gardner Wallace J. Composition, kit and method for reducing plaque formation, tooth decay and incidence of caries
CA2574572A1 (en) * 2004-07-19 2006-10-26 Baylor College Of Medicine Modulation of cytokine signaling regulators and applications for immunotherapy
US7868159B2 (en) * 2005-06-23 2011-01-11 Baylor College Of Medicine Modulation of negative immune regulators and applications for immunotherapy
EP2136832B1 (en) 2007-03-26 2015-09-02 General Regeneratives Limited Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies
JP2011505144A (ja) * 2007-11-30 2011-02-24 ベイラー カレッジ オブ メディシン 樹状細胞ワクチン組成物およびその使用
JP5759445B2 (ja) 2009-03-25 2015-08-05 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 病原体に対する哺乳類先天性免疫抵抗性の刺激のための組成物
WO2011038002A1 (en) 2009-09-22 2011-03-31 Yale University Immunogenic epitopes as targets for universal cancer vaccines
EP2741785B1 (en) 2011-07-12 2018-09-05 Philadelphia Health and Education Corporation Novel clostridium difficile dna vaccine
RU2491922C1 (ru) * 2012-04-26 2013-09-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Способ повышения биоцидного и лечебного действия крема-суспензии с энрофлоксацином
RU2527330C2 (ru) * 2012-07-05 2014-08-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ повышения биоцидного и лечебного действия крема - суспензии с метронидазолом
US9834610B2 (en) 2013-01-31 2017-12-05 Thomas Jefferson University Fusion proteins for modulating regulatory and effector T cells
WO2015116178A1 (en) 2014-01-31 2015-08-06 Thomas Jefferson University Fusion proteins for modulating regulatory and effector t cells
US10286065B2 (en) 2014-09-19 2019-05-14 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
WO2016138286A1 (en) 2015-02-26 2016-09-01 Stc.Unm Irgm and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
WO2017103944A1 (en) 2015-12-15 2017-06-22 Bharat Biotech International Limited Novel muramyl peptide derivative compound, synthesis and uses thereof
WO2020140007A1 (en) 2018-12-28 2020-07-02 University Of Rochester Gene therapy for best1 dominant mutations
WO2022198101A1 (en) 2021-03-19 2022-09-22 Trained Therapeutix Discovery, Inc. Compounds for regulating trained immunity, and their methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308450A (xx) * 1972-06-20 1973-12-27
US4001395A (en) * 1972-06-20 1977-01-04 Agence Nationale De Valorisation De La Recherche (Anvar) Hydrosoluble extracts of mycobacteria
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH613709A5 (en) * 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
US4082736A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
US4082735A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
GB1563561A (en) * 1976-06-23 1980-03-26 Daiichi Seiyaku Co Muramyldipeptide derivatives and process for the preparation thereof
FR2368282A1 (fr) * 1976-10-22 1978-05-19 Anvar Adjuvant immunologique constitue par le p-amino-phenyl de n-acetyl-muramyl-l-alanyl-d-isoglutamine
US4268505A (en) * 1978-04-13 1981-05-19 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition comprising a nitrogen-containing polysaccharide and an antibiotic agent, and a method of treating an infectious disease therewith
FI803077A (fi) * 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider

Also Published As

Publication number Publication date
IL60676A0 (en) 1980-09-16
SG38187G (en) 1988-01-15
NO157177B (no) 1987-10-26
MX9203368A (es) 1992-09-01
CA1183129A (en) 1985-02-26
DK319480A (da) 1981-01-26
HK85787A (en) 1987-11-27
NO157177C (no) 1988-02-03
FI75578C (fi) 1988-07-11
HU188861B (en) 1986-05-28
DE3068304D1 (en) 1984-07-26
AU541147B2 (en) 1984-12-20
EP0025495B1 (de) 1984-06-20
PL127481B1 (en) 1983-10-31
KR830003511A (ko) 1983-06-21
PL131613B1 (en) 1984-12-31
JPS5649397A (en) 1981-05-02
IE801533L (en) 1981-01-25
US4406890A (en) 1983-09-27
IE50145B1 (en) 1986-02-19
AU6078880A (en) 1981-01-29
ES8105971A1 (es) 1981-07-01
DK161025C (da) 1991-10-28
NZ194432A (en) 1983-09-02
US4414204A (en) 1983-11-08
NO802200L (no) 1981-01-26
FI802294A (fi) 1981-01-26
DK161025B (da) 1991-05-21
DD153843A5 (de) 1982-02-03
CS276965B6 (en) 1992-11-18
CS526280A3 (en) 1992-06-17
CY1381A (en) 1987-12-18
IL60676A (en) 1984-10-31
KR840001617B1 (ko) 1984-10-11
ES493633A0 (es) 1981-07-01
JPS6356239B2 (xx) 1988-11-07
ZA804487B (en) 1981-07-29
PT71607A (de) 1980-08-01
GR69314B (xx) 1982-05-14
SU1277905A3 (ru) 1986-12-15
SU1277906A3 (ru) 1986-12-15
PL225870A1 (xx) 1981-05-08
EP0025495A1 (de) 1981-03-25
AU6658181A (en) 1982-11-04
FI75578B (fi) 1988-03-31

Similar Documents

Publication Publication Date Title
MY8700554A (en) Lipophilic muramyl pertides processes for their preparation and their use
GB2055800B (en) Guanidinothiazoles and their preparation and use
JPS55129124A (en) Filter and its preparation
EG14600A (en) Preparing for combating theileriosis and their use
GB2063870B (en) 1-aryl-4-arylsulphonyl-1h-pyrazolol-3 compounds and processes for their preparation
IL60873A0 (en) 4-fluoro-3-phenoxy-benzylethers and their preparation
GB2052488B (en) 3 - vinyl - cephalosporins and their preparation
JPS565207A (en) Tireeliner and its preparation
GB2051062B (en) 3-vinyl-cephalosporin derivatives and their preparation
GB2063872B (en) Beta-amino-propionamide preparation
IL59584A0 (en) Microcapsules and their preparation
DE3064789D1 (en) New 25-hydroxy-24-oxocholestane derivatives and preparation thereof
GB2057434B (en) Preparation of -aminopropionamides
GB2009216B (en) Compounds processes for their preparation and their use
IL59882A0 (en) Alkoxyalkylidenehydrazino-pyridazines and process for their preparation
GB2045247B (en) 3-0-demethyl-fortimicins preparation
CY1334A (en) 17-cycloalkylmethyl-6-methylene-morphinane derivatives and their preparation
IL60541A0 (en) Tallysomicin derivatives and their preparation
ZA785005B (en) 2-guanidinomethyl-indolines and processes for their preparation
JPS5597252A (en) Catalyst and its preparation
DE3071819D1 (en) 5-thio-tetrazol compounds and their preparation
GB2050356B (en) A-halomethylamino compounds and their preparation
GB2065651B (en) Substituted-phenylpyridines and preparation
JPS55141232A (en) Xxray tomography device
GB2049689B (en) Nogamycin analogues and their preparation